These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17266555)

  • 1. HIV genetic diversity: biological and public health consequences.
    Butler IF; Pandrea I; Marx PA; Apetrei C
    Curr HIV Res; 2007 Jan; 5(1):23-45. PubMed ID: 17266555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development.
    Lal RB; Chakrabarti S; Yang C
    Indian J Med Res; 2005 Apr; 121(4):287-314. PubMed ID: 15817945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic diversity of HIV infection worldwide and its consequences].
    Peeters M; Delaporte E
    Med Trop (Mars); 1999; 59(4 Pt 2):449-55. PubMed ID: 10901846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV genetic diversity and its consequences].
    Roquebert B; Damond F; Brun-Vézinet F; Descamps D
    Pathol Biol (Paris); 2009 Mar; 57(2):142-8. PubMed ID: 18511216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of vaccines for HIV-1. Relevance of subtype-specific cellular immunity].
    Rodríguez AM; Turk G; Pascutti MF; Falivene J; Gherardi MM
    Medicina (B Aires); 2010; 70(6):543-54. PubMed ID: 21163746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Degree of HIV-1 Group M (HIV-1M) Genetic Diversity within Circulating Recombinant Forms: Insight into the Early Events of HIV-1M Evolution.
    Tongo M; Dorfman JR; Martin DP
    J Virol; 2015 Dec; 90(5):2221-9. PubMed ID: 26656688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy.
    Thomson MM; Pérez-Alvarez L; Nájera R
    Lancet Infect Dis; 2002 Aug; 2(8):461-71. PubMed ID: 12150845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travel and the spread of HIV-1 genetic variants.
    Perrin L; Kaiser L; Yerly S
    Lancet Infect Dis; 2003 Jan; 3(1):22-7. PubMed ID: 12505029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution of subtypes and recombinant of HIV. Situation in Argentina].
    Cómez Carrillo M; Salomón H; Pando MA; Kijak G; Avila MM
    Medicina (B Aires); 2001; 61(6):881-9. PubMed ID: 11808433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic.
    Bártolo I; Rocha C; Bartolomeu J; Gama A; Marcelino R; Fonseca M; Mendes A; Epalanga M; Silva PC; Taveira N
    Infect Genet Evol; 2009 Jul; 9(4):672-82. PubMed ID: 18562253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and time trends of HIV-1 variants in Poland: Characteristics of non-B clades and recombinant viruses.
    Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Rymer W; Zalewska M; Gąsiorowski J; Bociąga-Jasik M; Kalinowska-Nowak A; Garlicki A; Grzeszczuk A; Jankowska M; Lemańska M; Barałkiewicz G; Mozer-Lisewska I; Łojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Urbańska A
    Infect Genet Evol; 2016 Apr; 39():232-240. PubMed ID: 26851192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for an AIDS vaccine: three big questions, no easy answers.
    Garber DA; Silvestri G; Feinberg MB
    Lancet Infect Dis; 2004 Jul; 4(7):397-413. PubMed ID: 15219551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIV vaccines].
    Pialoux G; Slama L
    Presse Med; 2005 Nov; 34(20 Pt 2):1592-6. PubMed ID: 16314820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the human immunodeficiency virus.
    Brun-Vézinet F; Charpentier C
    Med Mal Infect; 2013 May; 43(5):177-84. PubMed ID: 23628423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
    Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L;
    Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo.
    Rodgers MA; Wilkinson E; Vallari A; McArthur C; Sthreshley L; Brennan CA; Cloherty G; de Oliveira T
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.
    Billings E; Sanders-Buell E; Bose M; Bradfield A; Lei E; Kijak GH; Arroyo MA; Kibaya RM; Scott PT; Wasunna MK; Sawe FK; Shaffer DN; Birx DL; McCutchan FE; Michael NL; Robb ML; Kim JH; Tovanabutra S
    PLoS One; 2015; 10(8):e0135124. PubMed ID: 26287814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular epidemiology of HIV: principle and its application].
    Takebe Y
    Nihon Rinsho; 2002 Apr; 60(4):652-61. PubMed ID: 11968769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges.
    Villabona-Arenas CJ; Domyeum J; Mouacha F; Butel C; Delaporte E; Peeters M; Mpoudi-Ngole E; Aghokeng AF
    Infect Genet Evol; 2015 Dec; 36():210-216. PubMed ID: 26371064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular variants of HIV-1 and their impact on vaccine development.
    Quinn TC
    Int J STD AIDS; 1998; 9 Suppl 1():2. PubMed ID: 9874106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.